HealthEquity Price/Book Ratio 2014-2024 | HQY

HealthEquity current price/book ratio as of January 19, 2025 is 4.19.

  • HealthEquity average price/book ratio for 2024 was 3.28, a 17.56% increase from 2023.
  • HealthEquity average price/book ratio for 2023 was 2.79, a 2.11% increase from 2022.
  • HealthEquity average price/book ratio for 2022 was 2.85, a 20.83% decline from 2021.

Price/book ratio can be defined as

HealthEquity Price/Book Ratio 2014-2024 | HQY

  • HealthEquity average price/book ratio for 2024 was 3.28, a 17.56% increase from 2023.
  • HealthEquity average price/book ratio for 2023 was 2.79, a 2.11% increase from 2022.
  • HealthEquity average price/book ratio for 2022 was 2.85, a 20.83% decline from 2021.

Price/book ratio can be defined as

Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$88.4B
Cencora (COR)$45.7B
Natera (NTRA)$23.1B
DiDi Global (DIDIY)$22B
ICON (ICLR)$18B
Avantor (AVTR)$14.7B
Viatris (VTRS)$13.9B
Revvity (RVTY)$13.9B
BioMerieux (BMXMF)$12.6B
CochLear (CHEOY)$12.1B
Solventum (SOLV)$11.6B
Medpace Holdings (MEDP)$10.9B
Doximity (DOCS)$9.7B
EUROFINS SCIENT (ERFSF)$9.7B
Charles River Laboratories (CRL)$9.5B
Sonic Healthcare (SKHHY)$8.2B
Bausch + Lomb (BLCO)$6.3B
Amplifon S.p.A (AMFPF)$5.9B
Organon (OGN)$4.1B
Sotera Health (SHC)$3.7B
BrightSpring Health Services (BTSG)$3B
Surgery Partners (SGRY)$2.6B
Concentras Parent (CON)$2.5B
GeneDx Holdings (WGS)$2.5B
Alignment Healthcare (ALHC)$2.3B
Ardent Health Partners (ARDT)$2.3B
Premier (PINC)$2B
PACS (PACS)$2B
GoodRx Holdings (GDRX)$1.7B
Teladoc Health (TDOC)$1.7B